Core Insights - Spectral AI has achieved 100% pediatric patient enrollment at burn centers for its pivotal study on the DeepView™ System, which is designed to validate an AI-driven algorithm for burn treatment [1][2][3] - The pivotal study is expected to be completed in Q4 2024, leading to a potential FDA approval for the DeepView™ System in 2025 [2] - The DeepView™ System utilizes proprietary multispectral imaging and has been trained against a database of over 340 billion clinically validated data points to assess burn wounds accurately [3][4] Company Overview - Spectral AI, Inc. is focused on medical diagnostics, particularly in wound care, with applications for burns and diabetic foot ulcers [4] - The DeepView System aims to provide objective and immediate assessments of wound healing potential, thereby improving patient outcomes and reducing healthcare costs [4]
Spectral AI Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study